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RESEARCH ARTICLE

Transcriptional Response of Mucoid Pseudomonas aeruginosa to
Human Respiratory Mucus
V. Cattoir,a,b G. Narasimhan,c D. Skurnik,d H. Aschard,e D. Roux,d R. Ramphal,f J. Jyot,f and S. Lorya
Department of Microbiology and Immunobiology, Harvard Medical School, Boston, Massachusetts, USAa; EA4655, Medical School, University of Caen Basse-Normandie,
Caen, Franceb; Bioinformatics Research Group, School of Computing and Information, Sciences, Florida International University, Miami, Florida, USAc; Division of Infectious
Diseases, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts, USAd; Department of Epidemiology, Harvard School
of Public Health, Boston, Massachusetts, USAe; and Division of Infectious Diseases and Global Medicine, Department of Medicine, University of Florida, Gainesville, Florida,
USAf

ABSTRACT Adaptation of bacterial pathogens to a host can lead to the selection and accumulation of specific mutations in their
genomes with profound effects on the overall physiology and virulence of the organisms. The opportunistic pathogen Pseudomonas aeruginosa is capable of colonizing the respiratory tract of individuals with cystic fibrosis (CF), where it undergoes evolution
to optimize survival as a persistent chronic human colonizer. The transcriptome of a host-adapted, alginate-overproducing isolate from a CF patient was determined following growth of the bacteria in the presence of human respiratory mucus. This stable
mucoid strain responded to a number of regulatory inputs from the mucus, resulting in an unexpected repression of alginate
production. Mucus in the medium also induced the production of catalases and additional peroxide-detoxifying enzymes and
caused reorganization of pathways of energy generation. A specific antibacterial type VI secretion system was also induced in
mucus-grown cells. Finally, a group of small regulatory RNAs was identified and a fraction of these were mucus regulated. This
report provides a snapshot of responses in a pathogen adapted to a human host through assimilation of regulatory signals from
tissues, optimizing its long-term survival potential.
IMPORTANCE The basis for chronic colonization of patients with cystic fibrosis (CF) by the opportunistic pathogen Pseudomonas

aeruginosa continues to represent a challenging problem for basic scientists and clinicians. In this study, the host-adapted,
alginate-overproducing Pseudomonas aeruginosa 2192 strain was used to assess the changes in its transcript levels following
growth in respiratory CF mucus. Several significant and unexpected discoveries were made: (i) although the alginate overproduction in strain 2192 was caused by a stable mutation, a mucus-derived signal caused reduction in the transcript levels of alginate biosynthetic genes; (ii) mucus activated the expression of the type VI secretion system, a mechanism for killing of other bacteria in a mixed population; (iii) expression of a number of genes involved in respiration was altered; and (iv) several small
regulatory RNAs were identified, some being mucus regulated. This work highlights the strong influence of the host environment in shaping bacterial survival strategies.
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I

ntroduction of bacteria into new environmental reservoirs, including tissues of infected human hosts, leads to large-scale reprogramming of their signal-transducing and regulatory networks to accommodate the conditions encountered in a particular
niche. Pathogenic microorganisms similarly adjust their metabolism to favor effective utilization of available nutrients, often in
competition with their hosts. Equally important is the activation
or repression of expression of factors allowing pathogens to overcome the action of the various host defense mechanisms. Moreover, when an infection leads to persistent colonization, it is occasionally accompanied by microevolution and selection for
variants with mutations in previously environmentally regulated
genes, resulting in stable expression of physiological or virulence
traits in the host. Mutations can be also selected to limit the production of potentially deleterious factors such as those targeted by
the immune defenses. These changes occur without horizontal
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acquisition of genes, and they are referred to as pathogenicityadaptive, or pathoadaptive, mutations (1, 2).
Among the most extensively studied examples of bacterial evolution within the infected host are those that arise from adaptive
mutations during the chronic respiratory disease of individuals
with CF (cystic fibrosis) (3). CF patients are colonized by a number of opportunistic bacterial pathogens, predominantly Pseudomonas aeruginosa, with specific strains coexisting in the respiratory tract for years or even decades. A number of genetic
alterations leading to the loss of motility, quorum sensing, and
production of lipopolysaccharide O-side chains and type IV pili
have been identified in isolates from patients with chronic CF
(4–6). The most widely recognized phenotype of P. aeruginosa
isolates from CF individuals acquired through pathoadaptive mutations is the overproduction of the alginate exopolysaccharide,
giving the colonies their characteristic mucoid appearance. The
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alginate capsule is a virulence factor protecting P. aeruginosa from
killing by phagocytes in the respiratory tract (7, 8). The increased
production of alginate in mucoid CF isolates is the result of mutations, most frequently in the gene encoding the anti-sigma factor MucA. In nonmucoid bacteria, MucA functions by limiting
alginate production through its inhibitory interaction with the
alternative sigma factor 22 (also named AlgU or AlgT), which
directs RNA polymerase to promoters of alginate biosynthetic
genes. Loss of MucA inhibition leads to high-level expression of
several AlgU-transcribed operons whose products are involved in
polymerization, modification, and transport of alginate (9).
We have previously used DNA microarrays to identify genes in
a nonmucoid laboratory strain that respond to the presence of
human respiratory mucus in the growth medium (10). When the
genes were exposed to mucus, an immediate repression of expression of flagellin was detected. The flagellin is not only the major
protein component of the bacterial motility apparatus, but this
protein is also a strong proinflammatory stimulant. This adaptive
response of reducing the expression of a surface molecule involved
in pathogen recognition very likely plays a role in the natural environment as well, where invertebrate predators of bacteria possess homologues of human Toll-like receptors (TLRs). It is therefore likely that mucus-induced suppression of flagellin synthesis
represents a rapid response to avoidance of immune recognition
by the flagellin receptor TLR5. A defect in flagellin synthesis is a
common pathoadaptive mutation observed in strains isolated
from chronically infected CF patients (11, 12). A number of mutations in various structural, regulatory, or assembly genes account for the loss of flagellar motility in such strains (4).
In the study described here, we built on our previous work on
identifying mucus-responsive genes, this time in a stable mucoid,
host-adapted CF isolate of P. aeruginosa. Analysis of the transcriptome of this strain provides an opportunity to study the consequences of environmental adaptation and pathoadaptive mutations for gene regulation in a manner not possible with genetically
engineered mucoid isolates of common laboratory strains such as
PAO1 or PA14. We used the method of deep sequencing-based
transcriptome analysis (RNA-seq) to monitor the levels of all transcripts in bacteria grown in the presence and the absence of human respiratory mucus. We uncovered several physiological responses by this mucoid P. aeruginosa strain, including unexpected
repression of alginate production in mucus with a concomitant
activation of the antibacterial type VI secretion system (T6SS),
that do not appear to be controlled by known regulatory mechanisms. Our results point toward a major contribution of the components of respiratory mucus in controlling the expression of virulence factors during chronic infection and thereby playing an
important role in bacterial survival and its ecological fitness in the
CF respiratory tract.
RESULTS AND DISCUSSION

Transcripome of P. aeruginosa 2192 determined by RNA-seq.
We used an isolate of P. aeruginosa (strain 2192) from a chronically infected CF patient (13) to probe its transcriptome during
growth on media containing human respiratory mucus. This
strain displayed a highly stable phenotype, with no loss of a mucoid colony appearance following inoculation of a single colony
and growth for 24 h at 37°C in minimal (M63; see Materials and
Methods) or rich (LB) liquid media and plating ca. 1,000 CFU on
the same media solidified with agar (data not shown). Strain 2192
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carried in its genome a mutation in the mucA gene with a substitution of a G for a T at base pair 538, replacing an aspartic acid
codon with a stop codon. No other obvious mutations in the genome of strain 2192 that could have contributed to the maintenance of the mucoid phenotype were identified (14). To gain new
insights into the regulatory networks that control gene expression
in a mucoid P. aeruginosa strain adapted to chronic persistence
within the CF lung, we used RNA-seq to compare transcriptomes
of P. aeruginosa 2192 grown in minimal medium and in the same
medium supplemented with pooled respiratory mucus collected
from CF patients. The growth kinetics of the culture grown on
minimal medium (referred to as the M-0 culture) showed that the
mucus supplement (referred to as the M-50 culture) increased the
growth rate in the exponential phase and the cell mass reached in
the stationary phase only mildly (data not shown). Total RNA was
isolated from P. aeruginosa 2192 grown to the late-exponential
phase, and, following rRNA depletion, the remaining RNA was
reverse transcribed into cDNA, fragmented, and sequenced using
Single Molecule Sequencing (SMS) technology and a Helicos sequencing platform.
A total of 35,130,649 (from M-0) and 25,010,555 (from M-50)
reads were obtained for each cDNA library (see Table S1A in the
supplemental material). Of these, 9,528,142 (from M-0) and
7,081,980 (from M-50) reads mapped uniquely to the genome of
P. aeruginosa 2192, totaling 83,044,324 and 59,420,268 bases of
sequenced P. aeruginosa 2192 cDNA, respectively. We utilized the
rRNA depletion method, and 16S rRNA and 23S rRNA were
largely removed, as assessed by the decreases of corresponding
peaks in the Bioanalyzer analysis (data not shown). However, a
high proportion of reads mapped to rRNA genes corresponding to
73.7% (M-0) and 75.2% (M-50) of the total number of mapped
reads. The average numbers of reads per region other than rRNA
were 213 (M-0) and 116 (M-50), with a coverage of 99.6% (M-0)
and 98.3% (M-50) of the 6,197 coding sequences (CDSs) represented by at least a single read.
Differentially expressed genes in the absence or presence of
CF mucus. The absolute and relative distributions of reads in two
media in the annotated genes of strain 2192 are shown in Fig. 1A
(see also Table S1B in the supplemental material). The most highly
expressed gene encoded the small regulatory RNA RsmY, accounting for ca. 15% of total reads. The genes PA2G_02646 (encoding a predicted membrane protein) and PA2G_02595 (gltK)
were most strongly activated and repressed in mucus, respectively.
To assess the reliability of RNA-seq in determining the relative
abundances of individual transcripts in minimal and mucuscontaining media, we used the identical total RNA samples and
determined by real-time quantitative reverse transcription-PCR
(qRT-PCR) the mRNA levels of six upregulated genes (katE, katA,
hcp1, katB, chiC, and cbpD) and two downregulated genes (oprD
and algD). The ratios of the transcripts from the M-0 and M-50
samples determined by RNA-seq to those obtained by qRT-PCR
resulted in an excellent concordance, with a Pearson correlation
value of 0.9823 obtained (Fig. 1B; see also Table S2 in the supplemental material). Therefore, RNA-seq appears to be a reliable
method for analyzing steady-state levels of mRNA in total RNA
samples.
We then organized the genes based on the ranking of normalized mRNA levels and grouped these into four categories: no, low,
medium, and high expression (see Fig. S1 in the supplemental
material). For the remainder of the article, we use this figure as a
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FIG 1 Analysis and validation of RNA-seq experiments. (A) Global analysis of transcript levels in P. aeruginosa 2192 by RNA-seq. M-0 and M-50 refer to
minimal media lacking and containing 50% respiratory mucus, respectively. The red line in the gray circle represents the baseline, and thin gray circular lines
represent 64-fold changes (or log2 ⫽ 6) in expression (i.e., RPKM M-50/M-0 ratio values) of each gene. Green and blue circles correspond to the expression of
each gene (represented as RPKM values) in bacteria grown under M-50 and M-0 conditions, respectively. In both of the colored circles, thin circular lines
represent an RPKM value of 2,500, with a limit at 10,000. The outermost circle represents the full strain 2192 genome, with a ⫻50 magnification of the genes for
which expression was confirmed by qRT-PCR (see Table S2 in the supplemental material). (B) Validation of RNA-seq results by qRT-PCR on selected genes.
Mean log2 ratios of values determined in the qRT-PCR experiments are plotted against the mean log2 ratios of values determined in RNA-seq experiments (see
Table S2 in the supplemental material).

reference when commenting on relative transcript level of a specific gene compared to the rest of the transcriptome.
The analysis of RNA-seq data and comparisons identified 656
genes with altered transcript levels, with 378 genes showing an
increase and 278 genes a decrease of at least 4-fold (i.e., log2 ⫽ 2)
in mRNA concentrations in bacteria grown under M-50 conditions compared to M-0 conditions (see Table S3 in the supplemental material). Differentially expressed genes were classified
into functional categories according to the PseudoCAP designations, occasionally requiring reannotation in strain 2192, based on
information from other sequenced strains. Among these 656
genes, approximately 20% coded for hypothetical proteins of unknown function, equally represented in RNA samples obtained
under both sets of conditions (see Fig. S2 and Table S3 in the
supplemental material). In the presence of mucus, expression of
genes coding for proteins involved in motility/attachment and the
protein secretion/export apparatus and related to phage, transposons, or plasmids was induced whereas expression of genes coding for proteins involved in energy metabolism and transport of
small molecules as well as genes coding for putative enzymes, secreted factors (toxins, enzymes, alginate), and two-component
regulatory systems was repressed.
Repression of alginate production by mucus. The overexpression of alginate in mucoid P. aeruginosa isolates from CF patients is due to mutations in regulatory genes, primarily in mucA,
encoding the antagonist of the alternative sigma factor AlgU (15).
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Stable derepression of the alginate biosynthetic pathways provides
a mechanism for producing copious amounts of this polysaccharide without environmental influences. The results of the RNAseq analysis showed that the entire group of genes encoding proteins involved in the synthesis, modification, and export of
alginate were highly expressed in the mucoid strain 2192 grown in
minimal media but that the levels of the corresponding transcripts
were reduced in media containing human mucus compared to
media lacking this supplement. Specifically, the mRNA levels for
each gene within the 12-gene cluster (algD, alg8, alg44, algK, algE,
algG, algX, algL, algI, algJ, algF, and algA) were reduced, with fold
changes between ⫺4.8 and ⫺9.4 (Fig. 2). No effect of the composition of media was observed for the moderately to highly expressed genes in the alginate regulatory operon (algU, mucABC,
and D), and none of the other known regulatory genes (algQ, algP,
algZ, algR, and algW) had a significant fold change in expression
(see Table S4A in the supplemental material). Interestingly, bacteria grown on agar plates containing 50% mucus appeared less
mucoid than those grown on media lacking mucus by visual inspection (Fig. 3A). Moreover, the effect of reduced transcription
of genes encoding alginate biosynthetic enzymes was confirmed
by quantitative determination of alginate production as measured
by the amount of uronic acid produced by cells (Fig. 3B).
The finding that mucus represses alginate production in
P. aeruginosa in a strain carrying a stable mutation in mucA, the
negative regulator of the AlgU sigma factor, raises the possibility
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FIG 2 Differential expression of selected virulence factor genes whose expression is influenced by mucus-containing media. Differences in the levels of
expression of virulence genes measured under M-0 and M-50 conditions are presented. Each gene is represented by the log2 of the fold change (i.e., RPKM
M-50/M-0 ratio values). The thick black circular line in the gray circle represents the baseline, and thin black circular lines represent 4-fold changes (i.e., a log2
scale). The outermost circle represents the full strain 2192 genome, with the regions corresponding to T6SS–HSI-I and alginate biosynthetic gene cluster
magnified ⫻30.

that the expression of this polysaccharide, even in mucoid strains,
is controlled by the components of the CF lung by novel mechanisms. The transcription of both the biosynthetic and regulatory
genes is initiated by the AlgU-containing RNA polymerase, and
yet mucus influences the repression of only the biosynthetic gene
cluster and not the operon containing the regulatory genes (15).
Therefore, it is unlikely that AlgU functions as a regulatory element playing a role in transducing the signals derived from mucus
toward the enhanced transcription of the algD-algA gene cluster.
Such regulatory control could include any one of the uncharacterized environmentally responsive transcription factors or utilize
posttranscriptional mechanisms that influence mRNA stability,
such as small regulatory RNAs. Alginate is a polysaccharide assembled via energy-dependent polymerization processes, and, due to
the copious amounts produced in a mucoid bacterium, its production represents a significant energy drain for the cells. The
large amount of alginate produced on agar plates in vitro that gives
colonies a mucoid appearance may represent an artifact of dysregulated synthesis in the absence of the signal provided by the
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respiratory mucus in vivo. Our findings suggest that during
chronic respiratory tract colonization of CF patients, the levels of
this polysaccharide are controlled by mucoid P. aeruginosa to provide amounts sufficient for its protective function during infection without imposing an energetically unsustainable metabolic
burden on the bacterium.
Mucus regulates the expression of virulence factors. The
transcript levels of a number of genes specifying virulence factors
(catalogued at http://www.mgc.ac.cn/VFs/main.htm) were also
altered by growth in mucus (see Table S4A in the supplemental
material). Among another large group of genes with increased
levels of transcript in mucus-containing media were those encoding the determinants of the type VI secretion system (T6SS) (see
Fig. 2; see also Table S4A in the supplemental material). This protein translocation apparatus delivers effectors to mammalian cells
and to adjacent bacteria by a contact-dependent mechanism (16–
18). The genome of P. aeruginosa encodes three complete T6SSs
(HSI-I, HSI-II, and HSI-III), but only the components and not the
regulators of the HSI-I gene cluster showed transcription in bac-
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FIG 3 Production of alginate in the absence or the presence of mucus. (A) Morphological aspect of colonies of P. aeruginosa 2192 and PA14 ⌬algD (used as a
negative control) on medium with no mucus (M-0) or 50% mucus (M-50) after 22 h of aerobic incubation at 37°C. (B) Quantitative estimation of alginate
produced for two same strains in the same culture conditions using the uronic acid assay.

teria grown in respiratory mucus that was enhanced by magnitudes ranging from 1.3- to 14.1-fold (see Table S4A in the supplemental material). The levels of transcripts were not evenly
distributed within the gene cluster, ranging from low to medium,
with those for tssA1, tagQ1, tssB1, and hcp1 expressed at an elevated level in mucus-containing media. Interestingly, the segments of mRNAs corresponding to 5= untranslated regions of a
number of genes within the HSI-I cluster were present in an unusually high abundance in mucus-containing media (see Fig. S3 in
the supplemental material). Mucus-induced expression of one of
the T6SS proteins, Hcp1, was confirmed by Western immunoblotting (see Fig. S4A in the supplemental material).
The main function of the HSI-I T6SS identified to date is bactericidal activity directed at other microorganisms following the
translocation of its three secreted substrates, TseI, TseII, and
TseIII, into the target bacterial cells (19). Increased expression of a
killing mechanism may provide a competitive advantage to
P. aeruginosa against other microorganisms that cohabitate the CF
respiratory tract (20–24). The HSI-I T6SS locus, together with
other genes involved in biofilm formation, is controlled by the
GacS/GacA two-component system (and its antagonist RetS), via
a regulatory mechanism involving two small regulatory RNAs,
RsmZ and RsmY, and its cognate RNA-binding protein, RsmA
(25, 26). The availability of the comprehensive transcriptome of
strain 2192 allowed us to compare the levels of expression of the
genes within the HSI-I locus and to compare those to the levels of
expression of the genes within the GacS/GacA regulon. In a previous study (27), the most significant GacS/GacA-dependent regulation coordinated with HSI-I was the activation of genes encoding the Pel and Psl polysaccharide. RNA-seq analysis of
P. aeruginosa 2192 clearly showed that the biosynthetic genes for
the Psl (PA2G_01334 to PA2G_01348) were not activated by mucus and that the mRNA levels of the majority of the genes were
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unaffected, with the exception of pslN, whose expression was activated 3.3-fold (see Table S4A in the supplemental material). The
transcripts for genes for the Pel polysaccharide (PA2G_02472 to
PA2G_02478) showed similar fluctuations, ranging from 2.2-fold
activation to ⫺2.4-fold repression (see Table S4A in the supplemental material). Similarly, the expression of the genes for cyanide production (hcnA, hcnB, hcnC) is GacS/GacA dependent (26)
and yet their mRNA levels show virtually no effect of mucus in the
medium (see Table S4A in the supplemental material). Another
group of genes repressed by the GacA/GacS pathway are the genes
specifying the type III secretion system. However, the results of
RNA-seq analyses of P. aeruginosa 2192 showed that the transcript
levels of these 36 genes (regulators, components of the secretion
machinery, and effectors) were not significantly regulated by mucus, with individual genes both modestly activated or repressed
(see Table S4A in the supplemental material). Genes approaching
significance in terms of mRNA levels were pscP, exsB, and pscL,
which were repressed ⫺3.8, ⫺3.3, and ⫺4.9-fold, respectively, in
cells grown in mucus. The levels of exoS, exoT, and exoY were also
not significantly influenced by the presence of mucus in the medium. We therefore conclude that the signals provided by the
mucus in regulating the genes for the HSI-1 T6SS do not utilize the
GacS/GacA pathway.
Genes for two functionally related proteins, chitinase- and
chitin-binding protein (ChiC and CbpD, respectively), were also
upregulated in P. aeruginosa 2192 grown in the presence of human
respiratory mucus, increasing from medium- to high-level expression (24.3-fold for chiC and 5.2-fold for cbpD) (see Table S3A
in the supplemental material). The increase of chitinolytic activity
was phenotypically confirmed by using by a chitinase assay (see
Fig. S4B in the supplemental material). Chitinases catalyze the
hydrolysis of chitin, a linear polymer of N-acetylglucosamine residues linked in ␤-1,4 glycosidic bonds. Several microbial chiti-
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nases have been described previously and are believed to function
primarily in nutrient acquisition in their natural habitats, since
mammalian tissues lack chitin. However, chitinase-deficient mutants of Listeria monocytogenes are attenuated in virulence and are
unable to spread into mouse liver (28), while an analogous mutant
of Legionella pneumophila has a reduced ability to persist in the
mouse lung (29). Bacterial chitin-binding proteins, often coregulated with chitinases, serve often as bacterial adhesins (30). To
date, there is no evidence that P. aeruginosa Chic and CbpD proteins have a function in P. aeruginosa infections, and high concentrations of chiC and cbpD mRNA in cells grown in the presence of
mucus may simply reflect the composition of the media, where a
polysaccharide mimic of chitin may induce expression of these
genes.
Mucus activates genes involved in protection of bacteria
against oxidative stress. Chronic colonizers of the CF respiratory
tract are contiguously exposed to oxidative stress created by the
action of influxing of neutrophils. When experiencing oxidative
stress, P. aeruginosa activates the expression of a group of genes via
the transcriptional regulator OxyR, which responds to signals that
include reactive oxygen species. The regulon controlled by OxyR
consists of a number of oxidative stress-responsive genes encoding two catalases (KatA and KatB), alkyl hydroperoxide reductase
B (AhpB), alkyl hydroperoxide reductase CF (AhpCF), and an
ankrin-like protein (AnkB) (31, 32). Another putative catalase,
KatE, is encoded in the genome of P. aeruginosa, but its role in
protecting the cells against oxidative stress is not known. Transcripts for all of these OxyR-regulated genes were expressed at
medium levels in minimal medium lacking mucus, but their expression was induced from 10- to 100-fold by growth in mucuscontaining media (see Table S4A in the supplemental material),
indicating that mucus directly or indirectly controls the activities
of this global transcriptional regulator. Alternatively, prooxidants released by neutrophils could indirectly control the expression of a number of genes involved in the observed oxidative
stress response. The increase of catalase activity was phenotypically confirmed by using a catalase assay (see Fig. S4C in the supplemental material).
Mucus influences several metabolic pathways in P. aeruginosa 2192. The ability of P. aeruginosa to occupy diverse niches,
including the human respiratory tract, requires it to be able to
carry out highly versatile energy metabolism (33). Its branched
respiratory chain terminates with multiple terminal oxidases and
denitrification enzymes. To support aerobic respiration, five terminal oxidases can be expressed in P. aeruginosa. Denitrification
involves conversion of nitrate to molecular nitrogen, allowing
P. aeruginosa to grow anaerobically. In addition to the denitrification, arginine catabolism can provide cellular ATP to P. aeruginosa growing anaerobically. Expression of genes involved in catabolism, as assessed by RNA-seq analysis, provides an insight into
the pathways favored by P. aeruginosa for optimal energy generation within the milieu of respiratory secretions and specific physical conditions. Strong induction of the cyoA-cyoE operon was
observed in P. aeruginosa growing on mucus (Fig. 4; see also Table S4B in the supplemental material). This operon encodes one of
the two quinol oxidases, an enzyme of relatively low affinity for
oxygen, indicating enhanced access of these cells to oxygen. Interestingly, P. aeruginosa can express two operons encoding Cbb3
oxidase type 1 (Cbb3-1) and Cbb3-2, and while the former was
expressed in both media, expression of the gene cluster for Cbb3-1
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(ccoN2-ccoO-ccoQ-ccoP2) was repressed (2.6- to 6.2-fold) in the
media containing respiratory mucus (see Table S1B and Table S4B
in the supplemental material). It is likely that the different terminal oxidases function under unique sets of environmental conditions, and it is apparent that mucus provides a signal for activation
of one (Cyo) and repression of another (Cbb3-2). Multiple terminal oxidases of such different characteristics and the differential
use of them under different conditions must contribute to adjust
its metabolism for optimal energy generation.
Denitrification consists of four sequential steps catalyzed by
specific metalloenzymes: reduction of nitrate to nitrite by nitrate
reductase (NarGHI), NirS-catalyzed reduction of nitrite to nitric
oxide (NO), and reduction of NO to N2O catalyzed by NO reductase NorCB, terminating with the conversion of N2O to N2 by
nitrous oxide reductase NosZ. Our RNA-seq data show a substantial reduction in transcript levels in mucus-grown P. aeruginosa
for genes encoding enzymes involved in denitrification and clustered in the nir, nos, and nor operons (Fig. 4; see also Table S4B in
the supplemental material). Moreover, the other anaerobic
energy-generating pathways involving arginine catabolism were
also repressed in media containing mucus. These pathways include the genes for the arginine/ornithine antiporter (arcD), arginine deaminase (arcA), catabolic ornithine carboyltransferase
(arcB), and carbamate kinase (arcC) (see Table S4B in the supplemental material). Total RNA used in the RNA-seq analysis was
isolated from the bacteria grown without any specific attempts to
create an atmosphere of reduced oxygen, and P. aeruginosa in the
respiratory tract has been reported to very likely grow under anaerobic or microaerophilic conditions (34, 35). Therefore, we cannot exclude the possibility that the conditions used in this work do
not exactly reflect those found in the CF respiratory tract. Moreover, the utilization of specific energy-generating pathways may
be influenced by other factors. For example, overproduction of
the alginate in mucoid strains may create anaerobic conditions for
individual cells, as it has been shown that the restriction of oxygen
diffusion imposed by alginate is not confined to mucoid isolates
but that the same effect is seen when alginate is added to media on
an isogenic nonmucoid revertant, leading to an increase of the
expression of denitrification genes (36). However, as shown
above, growth in mucus has a repressive effect on the expression of
alginate biosynthetic genes, which can lead to an increase in access
of oxygen to cells and a reduction in the expression of genes whose
products are involved in anaerobic energy generation.
Examination of the mRNA concentrations in cells grown in
minimal medium and medium supplemented with mucus revealed unexpected patterns of expression of several metabolic
genes, indicating that host adaption selected for stable genetic
changes affecting signal transduction and regulation of expression
of regulatory or signal transduction pathways. For example, we
have observed unexpected repression of several metabolic genes
involved in degradation of unusual natural products (see Table S3B in the supplemental material). Specifically, the dit genes
that were previously identified within the large 112-kb genomic
island have been found among P. aeruginosa isolates only in strain
PA2192 (14). These genes encode enzymes of abietane diterpenoid metabolism in Burkholderia xenovorans, and they were
shown to be positively regulated when bacteria were grown in
minimal medium supplemented with dehydroabietic acid (37).
Since the compounds have so far been identified only in plants and
wood pulp, it is unclear why the genes whose products are in-
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FIG 4 Differential expression of respiration genes in P. aeruginosa 2192 in M-0 and M-50 media. Each gene is represented by the log2 of the fold change (i.e.,
RPKM M-50/M-0 ratio values). The thick black circular line in the gray circle represents the baseline, and thin black circular lines represent 4-fold changes (i.e.,
a log2 scale). The outermost circle represents the full strain 2192 genome, with a ⫻30 magnification of the regions corresponding to cyo, nir, nor, and nos gene
clusters.

volved in their catabolism are even expressed in minimal medium
and repressed in the same medium containing 50% respiratory
mucus.
Similarly, we detected high-level expression of the glcDEFG
operon, encoding the glyoxylate oxidase subunits GlcDEF and
GlcG, a protein of unknown function, in nominal medium and its
repression (from ⫺69.6- to ⫺27.8-fold change) in medium with
the mucus supplement (see Table S3B in the supplemental material). The unlinked glcB gene (PA2G_04399) was highly expressed
in both types of media (see Table S1B in the supplemental material). In Escherichia coli, the glc operon is regulated by the GlcC
transcriptional activator located upstream of the glcDEFG operon
and is induced by growth on glycolate. The glyoxylate oxidase
catalyzes the formation of glyoxylate from glycolate, and malate
synthase (GlcB) converts glyoxylate to malate (38). The basis of
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mucus repression of the genes encoding the dit and glc genes remains unclear.
We detected an interesting example of environmental adaptation of P. aeruginosa 2192 in the regulation of the pathways for
utilization of acyclic monoterpenes. A limited number of bacterial
species, including P. aeruginosa, carry the atuR-atuABCDEFGH
gene cluster, encoding the regulator and the enzymes for utilization of the acyclic terpene citronellol family as the sole carbon
source (39, 40). The pathway feeds into the leucine/isovalerate
utilization pathway (referred to as either liuR-ABCDE or gnyRDBHAL), leading to the formation of acetyl-coenzyme A (CoA).
The expression of atu genes is regulated, and they are expressed
only in the presence of acyclic monopteroids and not in the presence of glucose or leucine/isovalerate substrates of the Liu pathway (41). AtuR is a repressor, binding as a dimer to two 13-bp
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inverted-repeat sequences in the atuA promoter region (42). In
our RNA-seq analysis, several of the genes involved in the metabolism of acyclic terpenes, atuBCDEFG, showed higher (between
2.2- and 8.7-fold) expression in minimal medium than in the
same medium containing human respiratory mucus (see Table S1B and Table S3B in the supplemental material). The mRNA
level for the AtuR repressor gene was not influenced by mucus;
neither was the level of atuA and atuH transcripts. In contrast, the
liu (gny) genes were expressed poorly in minimal medium but
were activated by mucus (see Table S3A in the supplemental material). An increase in the expression of the liu genes induced by
leucine or isovalerate very likely present in mucus and simultaneous repression of atu genes could explain why the levels of these
two gene clusters were reciprocal in cells grown in the presence
and absence of mucus. However, the basis for high-level expression of the atu genes in media containing glucose and lacking the
substrate inducer is less clear. The protein sequences of the 198amino-acid AtuR proteins in sequenced P. aeruginosa genomes
are nearly identical, with a single difference in the 2192 sequence
(D197N) from that of PAO1. The 13-bp inverted DNA sequences
of the operator regions in PAO1 and 2192 are also identical. However, three nucleotide substitutions can be found in the 40-bp
regions separating these inverted repeats. Although these differences could account for the constitutive expression of the atuABCDEFGH cluster in the absence of substrate, the genes are still
repressed in mucus, suggesting that additional regulatory mechanisms may control their expression in strain 2192 and possibly
other strains adapted to chronic persistence in the CF respiratory
tract.
Regulation of the genes of flagellar motility. We have previously reported that in PAK, a nonmucoid P. aeruginosa strain, the
transcription of the flagellin gene (fliC) is repressed in the presence of mucus whereas the rest of the apparatus of flagellar biogenesis is unaffected (10). This effect likely involves recognition of
the host environment by the bacterial pathogen, leading to repression of expression of the flagellin, a major proinflammatory ligand
of P. aeruginosa, recognized by the TLR5 receptor (43). In strain
2192, we observed a significant increase in transcript levels of the
genes involved in the assembly of flagella, while expression of its
fliC gene was activated 1.9-fold (see Table S1B and Table S4A in
the supplemental material). It is difficult to interpret these results
in light of the observation that this strain is nonmotile and lacks
assembled flagella. One possible explanation is that the shutoff of
flagellin synthesis in a nonmucoid strain requires the presence of
the assembled hook (FlgE) (44), which is not present in the absence of a flagellum. Thus, the flagellar shutoff in nonmucoid
strains is essential for avoiding early recognition by the innate host
defenses, and this regulatory mechanism is eliminated in this
strain, which is adapted to survival in the chronically infected
hosts. The genetic basis of this observation was not apparent from
the analysis of the sequence polymorphisms present in the sequences of the structural and regulatory flagellar loci of strain
2192 (14).
Detection of sRNAs. The strand-specific sequencing platform
of the Helicos technology can be used to identify small RNAs
(sRNAs). Thirty-four candidate sRNAs, including 10 novel small
RNAs, were identified in strain 2192 (see Table S5 in the supplemental material) (45). Of these, two were differentially expressed
under the conditions used here. One (PA2G_03487.1) was highly
expressed in minimal medium, but expression was dramatically
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repressed in the presence of mucus (fold change, ⫺117.3), while
expression of the second (PA2G_05393.1) was significantly induced in the presence of mucus (fold change, 8.0) (see Table S5 in
the supplemental material). The existence of both of these RNA
species was validated by Northern blot analysis (not shown).
Therefore, it is conceivable that these two sRNAs have a regulatory
function in P. aeruginosa in the CF mucus environment. Their
mRNA targets are currently being investigated using RNA-seq of
wild-type P. aeruginosa 2192 and its mutants lacking the sRNA
genes.
In conclusion, we used RNA-seq to identify genes in a mucoid
CF isolate of P. aeruginosa whose transcript levels are influenced
by growth in human respiratory mucus. We uncovered unexpected changes in the expression of genes involved in immune
avoidance (alginate), survival under oxidative stress (catalases),
and bacterial niche competition (the T6SS) and in a number of
metabolic functions. In certain instances, the control of expression of these genes appeared to function without utilization of
previously described regulatory mechanisms. Our findings suggest the existence of signal transduction and regulatory pathways
in P. aeruginosa, and likely in other human pathogens, that can be
detected only when bacteria are exposed to specialized environments that closely mimic the contents of human tissues. Application of molecular techniques should provide a wealth of information about novel mechanisms that control bacterial adaptation to
host environments during infection.
MATERIALS AND METHODS
Bacterial strains and growth conditions. For RNA-seq, P. aeruginosa
2192 (13) was grown at 37°C in two different media. Expectorated sputum
(5 to 10 ml) (referred to here as mucus) from 25 CF patients was retrieved
from the Hospital Microbiology Laboratory at the University of Florida
Medical Center and kept frozen at ⫺70°C until needed. This material was
used with supplemented 50% (vol/vol) or not solid (1.5% agar) M63
minimal medium [15 mM (NH4)2SO4, 22 mM KH2PO4, 40 mM
K2HPO4, 1 mM MgSO4, 25 M FeCl2, 10 mM D-glucose, 9 mM L-lactic
acid]. Prior to use, mucus was sterilized by UV irradiation for 30 min in
Stratagene Stratalinker 1800 (Agilent Genomics). Some mutants from the
P. aeruginosa PA14 transposon insertion mutant library (46) were used for
confirmatory phenotypic assays.
Oligonucleotides, PCR, and DNA sequencing. All synthesized oligonucleotides were obtained from Invitrogen (see Table S6 in the supplemental material), and confirmatory DNA sequencing was performed at
Genewiz Inc. (Cambridge, MA). PCR techniques were performed in accordance with standard protocols, and DNA fragments were purified with
a QIAquick PCR purification or QIAquick gel extraction kit (Qiagen).
RNA isolation. Bacteria were cultured (for 22 h at 37°C) to the lateexponential-growth phase on solid M63 agar plates, and total RNA was
extracted using the hot phenol method. Residual chromosomal DNA was
removed by treating samples with a Turbo DNA-free kit (Ambion).
DNase-treated RNA samples were quantified using a NanoDrop 1000
spectrophotometer (Thermo Scientific), and the integrity of the results
(RNA integrity number [RIN] ⬎ 8) was assessed using an Agilent 2100
bioanalyzer.
For RNA-seq analysis, a MICROBExpress kit (Ambion) was used according to the manufacturer’s recommendations to remove the 23S and
16S rRNA from the total RNA samples. To evaluate the degree of rRNA
depletion, the samples were analyzed using an Agilent 2100 bioanalyzer.
Quantitative RT-PCR. qRT-PCR experiments were performed using
a Kapa SYBR Fast One-Step qRT-PCR kit (Kapa Biosystems) and an Eppendorf Mastercycler ep realplex instrument (Eppendorf) with the following program: 42°C for 5 min, 95°C for 5 min, and 40 cycles of 95°C for
3 s and 60°C for 20 s. Transcript levels in each sample (without rRNA
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depletion) were determined by absolute quantification using serial dilutions of PCR products (47). Expression of the rpsL gene as a housekeeping
control gene was measured. Each experiment was performed in duplicate.
cDNA synthesis and preparation of the library for high-throughput
sequencing. cDNA was prepared and modified for Helicos sequencing as
previously described (48). Briefly, first-strand cDNA was synthesized
from 800 ng of RNA, using 1.2 g of random hexamer primers and
1,000 U of Superscript III reverse transcriptase (Invitrogen). RNA was
removed using RNase H and RNase A, and cDNA was sheared at 4°C by
sonication using a Misonix 4000 sonicator (Qsonica) with the amplitude
set at 60% for 20 min (20 s on/off pulses), generating fragments of 60 to
200 nt. Sheared cDNA was treated with terminal transferase (NEB) and
dATP, generating the 100-to-200-nt 3= poly(A) tail that is necessary for
Helicos sequencing. The samples were purified with a MinElute kit (Qiagen) and then quantified spectrophotometrically using a NanoDrop 1000
spectrophotometer (Thermo Scientific). The samples were sequenced using a HeliScope single-molecule sequencer (Helicos Biosciences) at the
Molecular Biology Core Facilities of the Dana-Farber Cancer Institute
(Boston, MA).
RNA-seq data analysis. The poly(T) tail of the raw reads was removed
by filtering using the Helisphere program (Helicos Biosciences) and then
mapped against the genomic sequence of P. aeruginosa 2192 (GenBank
accession no. CH482384.1) using CLC Genomics Workbench software
v5.1 (CLC bio). The number of reads uniquely aligned to each genomic
position (coding sequence, putative small RNA) was determined using
BEDTools software v2.16.2 (49). Since the genome sequence of P. aeruginosa 2192 is incomplete, the number of reads aligning to rRNA regions
and some sRNAs (e.g., Prrf1 and Prrf2) was evaluated by mapping reads
against the genomic sequence of P. aeruginosa PAO1 (GenBank accession
no. AE004091.2). To normalize the expression of genes in different RNAseq samples, values corresponding to the number of reads per kilobase per
million mapped (RPKM) were calculated as follows: (number of reads for
the gene ⫻ 109)/(total number of reads ⫻ size of the gene). Differentially
expressed genes were identified using a log2 absolute fold change value
greater than 2. Products of differentially expressed genes were classified by
functional category according to PseudoCAP function classes (http:
//www.pseudomonas.com/). RKPM values for each gene were plotted and
visualized as a circle using the Circos program (50). The sequence coverage per base was plotted and visualized using the genome browser Artemis
v13.0 (51). Identification of putative small RNAs was performed using a
program created in-house, and the results were compared to the list generated previously (45).
Uronic acid assay. Alginate production was quantified as previously
described (52). Briefly, P. aeruginosa 2192 cells grown on M63 minimal
medium plates for 22 h at 37°C were collected and washed twice in
phosphate-buffered saline (PBS). The alginate in the supernatants was
precipitated with 1 vol of ice-cold isopropanol. After centrifugation, the
pellet was resuspended in water and treated with DNase I and RNase A for
1 h at 37°C followed by proteinase K digestion for an additional hour at
37°C. The uronic acid concentrations were determined by the uronic acid
assay (53). Uronic acid concentrations were determined using a standard
curve with brown alga alginate (Sigma). The amount of alginate in each
sample was normalized to the number of cells per sample. Each experiment was performed in duplicate.
Western blot analysis. Production of Hcp1 protein was evaluated by
Western blot analysis as previously described using specific anti-Hcp1
antibodies (54). P. aeruginosa 2192 cells were grown on M63 plates for
20 h, 22 h, and 30 h at 37°C. Total proteins were extracted using BugBuster
protein extraction reagent (Novagen) according to the manufacturer’s
recommendations, and 1 g of proteins was loaded per lane. P. aeruginosa
PA14 ⌬hcp1 was used as a negative control. Each experiment was performed in duplicate.
Chitinase and catalase assays. The chitinase activity was determined
using a chitinase assay kit, fluorometric (Sigma), whereas the catalase
activity was estimated using an Amplex Red catalase assay kit (Invitro-
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gen). For both assays, P. aeruginosa 2192 cells were grown on M63 plates
for 22 h at 37°C, and total proteins were extracted using BugBuster protein
extraction reagent (Novagen) according to the manufacturer’s recommendations. PA14 ⌬chiC and PA14 ⌬katA were used as negative controls
in the chitinase and catalase assays, respectively. Both activities in each
sample were normalized to the number of cells per sample. Each experiment was performed in duplicate.
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